Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;260(4):969-74.
doi: 10.1007/s00415-012-6733-x. Epub 2012 Nov 9.

Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy

Affiliations

Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy

Arne Fischmann et al. J Neurol. 2013 Apr.

Abstract

The purpose of this ethics approved trial was to correlate quantitative MRI with functional abilities in both ambulant and non-ambulant Duchenne muscular dystrophy (DMD). Twenty patients with genetically confirmed DMD were recruited. Physical assessment was performed using the motor function measurement (MFM) scale. Axial 3T MRI scans of the thighs were acquired using T1-weighted in- and opposed-phase images (TR = 20 ms, TE1 = 2.45 ms, TE2 = 3.68 ms, flip angle = 15°) to calculate the relative fat fraction according to the two-point Dixon method in the knee extensors, flexors, and adductor muscles. The average MFM was 65.3 % and correlated negatively to age (r (2) = 0.60). Overall mean fat fraction correlated positively to age (r (2) = 0.51-0.64). An average of 5 % increase in mean fat fraction per year was calculated. Mean fat fraction of the quadriceps showed a high negative correlation (r (2) = 0.93) to the D1 (standing position and transfers) component of the MFM. A cutoff for mean fat fraction of 50 % predicted loss of ambulation with a sensitivity of 100 % and a specificity of 91 %. Therefore, quantitative muscle MRI seems to be a promising endpoint for short clinical trials evaluating the effect of newer treatments on the time of loss of ambulation in DMD.

PubMed Disclaimer

References

    1. Neuromuscul Disord. 2012 Oct 1;22 Suppl 2:S107-10 - PubMed
    1. Neuromuscul Disord. 2011 Jun;21(6):396-405 - PubMed
    1. J Neurol. 2011 Jul;258(7):1333-40 - PubMed
    1. J Magn Reson Imaging. 1994 Jan-Feb;4(1):59-64 - PubMed
    1. Magn Reson Med. 2011 Nov;66(5):1293-302 - PubMed

Publication types

LinkOut - more resources